Pharmacological properties of the postsynaptic inhibition by Purkinje cell axons and the action of gamma-aminobutyric acid on deiters NEURONES.
D000200:Action Potentials; D000613:Aminobutyrates / Q000494:pharmacology* / Q000502:physiology; D000818:Animals; D001369:Axons; D001534:Bemegride / Q000494:pharmacology; D002415:Cats; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004594:Electrophysiology; D004983:Ethanolamines / Q000494:pharmacology; D005071:Evoked Potentials; D006898:Hydroxylamines / Q000494:pharmacology; D008564:Membrane Potentials; D009638:Norepinephrine / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000494:pharmacology; D010852:Picrotoxin / Q000494:pharmacology; D011689:Purkinje Cells / Q000187:drug effects* / Q000502:physiology*; D011984:Sensory Receptor Cells / Q000502:physiology*; D013331:Strychnine / Q000494:pharmacology; D013569:Synapses / Q000187:drug effects* / Q000502:physiology*; D000637:Transaminases / Q000502:physiology*; D014726:Vestibular Nuclei / Q000187:drug effects*
D000613:Aminobutyrates; D001534:Bemegride; D003983:Dibenzylchlorethamine; D004298:Dopamine; D004983:Ethanolamines; D006898:Hydroxylamines; D009638:Norepinephrine; D010433:Pentylenetetrazole; D010852:Picrotoxin; D013331:Strychnine; D000637:Transaminases